relacorilant
CORT125134-452
Phase 3 small_molecule active
Quick answer
relacorilant for Cushing Syndrome is a Phase 3 program (small_molecule) at CORCEPT THERAPEUTICS INC with 2 ClinicalTrials.gov record(s).
Program details
- Company
- CORCEPT THERAPEUTICS INC
- Indication
- Cushing Syndrome
- Phase
- Phase 3
- Modality
- small_molecule
- Status
- active